Related Experiment Videos
[Should the development of virological diagnostic methods influence our practical approach?]
J L Pujol1, G Barneon, F B Michel
1Service des Maladies respiratoires, Hôpital de l'Aiguelongue, Montpellier.
Revue De Pneumologie Clinique
|January 1, 1989
Summary
Diagnosing respiratory viral infections in immunocompromised patients is crucial. Advanced methods like in situ hybridization and specific antibody tests improve detection and guide new antiviral treatments.
Area of Science:
- * Respiratory medicine
- * Virology
- * Immunology
Context:
- Respiratory viral infections pose significant risks to immunocompromised individuals, leading to frequent and severe acute and chronic conditions.
- Accurate diagnosis is essential for managing these infections and improving patient prognosis.
- Viruses are implicated in chronic respiratory diseases, impacting long-term lung function.
Purpose:
- To review current and emerging diagnostic methods for respiratory viral infections in immunocompromised patients.
- To highlight the importance of timely and accurate viral detection for effective patient management.
- To discuss the role of novel diagnostic techniques in guiding antiviral treatment strategies.
Summary:
- Routine diagnostic methods include direct immunofluorescence/immunoenzymatic techniques and virus isolation from cell cultures, with enhanced sensitivity through methods like fast culture.
- In situ hybridization using DNA probes offers a promising new approach to detect viral genomes within infected cells.
- Serum IgM assays are preferred over conventional serology for detecting active infections, despite potential inconstancy in immunocompromised patients.
Impact:
- Improved diagnostic accuracy will facilitate the timely initiation of appropriate antiviral treatments.
- Advancements in virological diagnostics are expected to enhance the management and outcomes of respiratory viral infections in vulnerable populations.
- The development of new diagnostic tools supports the future implementation of targeted antiviral therapies.